DOI QR코드

DOI QR Code

Liver Cancer Mortality Characteristics and Trends in China from 1991 to 2012

  • Fang, Jia-Ying (Department of Preventive Medicine, Shantou University Medical College) ;
  • Wu, Ku-Sheng (Department of Preventive Medicine, Shantou University Medical College) ;
  • Zeng, Yang (Department of Preventive Medicine, Shantou University Medical College) ;
  • Tang, Wen-Rui (Department of Preventive Medicine, Shantou University Medical College) ;
  • Du, Pei-Ling (Department of Preventive Medicine, Shantou University Medical College) ;
  • Xu, Zhen-Xi (Department of Preventive Medicine, Shantou University Medical College) ;
  • Xu, Xiao-Ling (Department of Preventive Medicine, Shantou University Medical College) ;
  • Luo, Jia-Yi (Department of Preventive Medicine, Shantou University Medical College) ;
  • Lin, Kun (Department of Preventive Medicine, Shantou University Medical College)
  • Published : 2015.03.18

Abstract

Purpose: To investigate the distribution of liver cancer mortality as well as its developing trend from 1991 to 2012, forecast the future five-year trend, and provide a basis for the comprehensive prevention and management. Materials and Methods: Mortality data for liver cancer in China from 1991 to 2012 were used to describe characteristics and distribution of liver cancer mortality. Trend surface analysis was used to study the geographical distribution of liver cancer mortality. Curve estimation, time series modeling, gray modeling (GM) and joinpoint regression were used to predict and forecast future trends. Results: The mortality rate of liver cancer has constantly increased in China since 1991. Rates in rural areas are higher than in urban areas, and in males are higher than in females. In addition, our data predicted that the trend will continue to increase in the next 5 years. The age-specific mortality of liver cancer increases with age and peaks in the group of 80-84 years old. Geographical analysis showed the liver mortality rate was higher in the southeast provinces, such as Jiangsu, Zhejiang and Guangdong, and southwest regions like Guangxi Province. Conclusions: The standardized mortality rate of liver cancer in China has consistently increased from 1991 to 2012, and the upward trend is predicted to continue in the future. Much better prevention and management of liver cancer is needed in high mortality areas (the southwestern and southeastern parts of China) and high mortality age groups (80- to 84-year-olds), especially in rural areas.

Keywords

Liver cancer;standardized mortality;epidemiological characteristics;geographic distribution;prediction

Acknowledgement

Supported by : National Science Foundation of China

References

  1. Box GE, Jenkins GM, Reinsel GC (2013). Time series analysis: forecasting and control. Wiley, New York.
  2. Chen J, Lu J, Zhu Y, et al (2010). A thirty-one year prospective follow-up program on the HBsAg carrier state and primary liver cancer in Qidong, China. Zhonghua liu xing bing xue za zhi, 31, 721-6.
  3. Chen JG, Zhang SW, et al (2011). Liver cancer epidemic in China: past, present and future. Seminars Cancer Biol, 21, 59-69. https://doi.org/10.1016/j.semcancer.2010.11.002
  4. Cheng L, Tan L, Zhang L, et al (2013). Chronic disease mortality in rural and urban residents in Hubei Province, China, 2008-2010. BMC Public Health, 13, 1-9. https://doi.org/10.1186/1471-2458-13-1
  5. China health statistics yearbook (2005). Beijing: Peking Union Medical College Publication House.
  6. China health statistics yearbook (2006). Beijing: Peking Union
  7. Medical College Publication House. China health statistics yearbook (2007). Beijng: Peking Union
  8. Medical College Publication House. China health statistics yearbook (2008). Beijing: Peking Union Medical College Publication House.
  9. Chen (2008). The third national mortality retrospective sampling survey report. Beijing: Peking Union Medical College Publication House.
  10. Ferlay J, Parkin D, Pisani P, et al (1998). GLOBOCAN 1: cancer incidence and mortality worldwide. Lyon, France: IARC press.
  11. Ferlay J (2001). GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. Lyon, France: IARC press.
  12. He Z, Han S, Cui D, et al ( 2008). Discussion on statistic of spatial autocorrelation analysis. Chin J Schisto Control, 20, 315-7.
  13. Huang S, Wang W, Zeng C, et al (2013). Application of gray metabolic GM (1, 1) model in prediction of annual total yields of Chinese aquatic products. Asian Agricultural Res, 5, 21-5.
  14. Kensler TW, Qian G-S, Chen J-G, et al (2003). Translational strategies for cancer prevention in liver. Nature Rev Cancer, 3, 321-9. https://doi.org/10.1038/nrc1076
  15. Luo R-H, Zhao Z-X, Zhou X-Y, et al (2005). Risk factors for primary liver carcinoma in Chinese population. World J Gastroenterol, 11, 4431. https://doi.org/10.3748/wjg.v11.i28.4431
  16. Mao Z, Wu B (2007). Urban-rural, age and gender differences in health behaviours in the Chinese population: findings from a survey in Hubei, China. Public Health, 121, 761-4. https://doi.org/10.1016/j.puhe.2007.02.015
  17. National Office for Cancer Prevention and Control (2008). Survey of cancer mortality in China 1990-1992. People Health Publishing House. 1-629.
  18. Qiu D, Katanoda K, Marugame T, et al (2009). A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004). Intern J Cancer, 124, 443-8. https://doi.org/10.1002/ijc.23911
  19. Shi X-J, Au WW, Wu K-S, et al (2014). Mortality characteristics and prediction of female breast cancer in china from 1991 to 2011. Asian Pac J Cancer Prev, 15, 2785. https://doi.org/10.7314/APJCP.2014.15.6.2785
  20. Stewart B, Kleihues P (2003). World Cancer Report. Lyon France:IARC press.
  21. Tang W-R, Fang J-Y, Wu K-S, et al (2014). Epidemiological characteristics and prediction of esophageal cancer mortality in China from 1991 to 2012. Asian Pac J Cancer Prev, 15, 6929-34. https://doi.org/10.7314/APJCP.2014.15.16.6929
  22. Wang YB, Lan LZ, Ye BF, et al (1983). Relation between geographical distribution of liver cancer and climateaflatoxin B1 in China. Sci Sin B, 26, 1166-75.
  23. Zhao P, Chen Wc (2008). Chinese cancer registry annual report, 2004. Beijing: Peking Union Medical College Publication House.
  24. Zhao P, Chen Wc (2009). Chinese cancer registry annual report, 2008-cancer incidence and mortality in Chinese cancer registration areas in 2005. Beijing: Military Medical Science Press.
  25. Zhao P, Chen Wc (2010). Chinese cancer registry annual report 2009-cancer incidence and mortality in Chinese Cancer registration areas in 2006. Beijing: Military Medical Science Press.
  26. Zhao P, Chen Wc (2011). Chinese cancer registry annual report 2010-cancer incidence and mortality in Chinese Cancer registration areas in 2007. China, Beijing: Military Medical Science Press.
  27. Zhao P, Chen Wc (2012). Chinese cancer registry annual report,2011. Beijing, China: Military Medical Science Press.

Cited by

  1. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway vol.13, pp.1, 2015, https://doi.org/10.1186/s12957-015-0717-0
  2. Characteristics and Prediction of Lung Cancer Mortality in China from 1991 to 2013 vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5829
  3. The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case–Control Study vol.8, pp.10, 2016, https://doi.org/10.3390/nu8100624
  4. Liver Cancer Mortality at National and Provincial Levels in Iran Between 1990 and 2015: A Meta Regression Analysis vol.18, pp.1, 2018, https://doi.org/10.5812/hepatmon.62009